ArticleJournal of medical biochemistry2026
Effects of sacral nerve magnetic stimulation on oxidative stress, inflammation and coagulation function in patients with neurogenic bladder after spinal cord injury.
Article in Journal of medical biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study investigated the effect of sacral nerve magnetic stimulation (SNM) on the neurogenic bladder (NB) following spinal cord injury (SCI). Pay close attention to the changes in serum oxidative stress factors, inflammatory factors and coagulation function. Methods: A total of 134 SCI-induced NB patients admitted between February 2021 and January 2025 were enrolled. All participants received information-motivation-behavioural skills (IMB) management, and patients were grouped according to their treatment regimen: a conventional group (n=71) receiving conventional treatment and an SNM group (n = 63) treated with SNM (20 Hz frequency, 1 Tesla intensity, 20-minute sessions, once a day, 5 times a week, for 4 consecutive weeks). Laboratory analyses included coagulation markers (D-dimer, fibrinogen), oxidative stress indicators (superoxide dismutase [SOD], glutathione peroxidase [GSH-Px], and malondialdehyde [MDA]), and inflammatory mediators (IL-1<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">β</span>, IL-6, TNF-<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span>, and high-sensitivity C-reactive protein [hs-CRP]). Results: Coagulation function also improved, with lower D-dimer and fibrinogen levels in the SNM group (P< 0.05). Regarding oxidative stress, the SNM group exhibited higher SOD and GSH-Px activity alongside reduced MDA levels (P< 0.05). Furthermore, inflammatory markers (IL-6, TNF-<span style="color: rgb(32, 33, 34); font-family: sans-serif; font-size: 16px; background-color: rgb(248, 249, 250);">α</span>) were lower in the SNM group (P< 0.05). Conclusions: SNM can alleviate the stress response and inflammatory response of patients with SCI-induced NB, relieve the hypercoagulable state of blood, and has certain clinical application value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.